Related Experiment Video
Updated: May 19, 2026
09:29
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
CD74: a potential novel target for triple-negative breast cancer
Buxian Tian1, Yuhong Zhang, Nan Li
1Department of Neurology, First Affiliated Hospital of Liaoning Medical College, Jinzhou, Liaoning Province, China.
Summary
CD74 protein is highly expressed in breast cancer, correlating with metastasis and poorer survival. This marker shows consistent expression in triple-negative breast cancer, suggesting its potential as a diagnostic tool.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer management requires understanding cellular markers.
- CD74 expression in breast cancer stem cells is not fully elucidated.
- Identifying novel biomarkers is crucial for targeted therapies.
Purpose of the Study:
- To evaluate CD74 expression in breast cancer.
- To determine the clinical implications of CD74 in breast cancer.
- To assess CD74 as a potential biomarker for triple-negative breast cancer.
Main Methods:
- Analysis of 580 breast cancer specimens.
- Immunohistochemical assessment of CD74 protein expression.
- Statistical analysis including Cox regression for prognostic significance.
Main Results:
- CD74 was expressed in 80.69% of breast cancer cases.
- CD74 expression correlated significantly with lymph node metastasis and triple-negative breast cancer.
- High CD74 expression was linked to increased liver metastasis and worse survival.
- CD74 was identified as an independent prognostic factor.
Conclusions:
- CD74 is frequently expressed in breast cancer.
- CD74 is a potential prognostic and diagnostic marker, especially for triple-negative breast cancer.
- Further research into CD74 could improve breast cancer management strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...